On the other hand, the regulation of co-inhibitory molecules such as PD-L1, Tim-3, TIGIT, and CTLA4 by cancer cells, Tregs, TAMs, DCs, and MDSCs can exhaust the anticancer potency of cytotoxic CD8 + T lymphocytes [234]. This evidence concerns the gene CD8A and cancer.